Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of the World Health Organization classification and clonality assessment of posttransplant lymphoproliferative disorders on disease management.
Mourad WA, Tulabah A, Al Sayed A, Raja M, Khafaga Y, El Gamal H, Al Shabanah M, Al Meshari K, Al Shaibani K, Ezzat A. Mourad WA, et al. Among authors: al shabanah m, al sayed a, al meshari k, al shaibani k. Arch Pathol Lab Med. 2006 Nov;130(11):1649-53. doi: 10.5858/2006-130-1649-TIOTWH. Arch Pathol Lab Med. 2006. PMID: 17076526 Free article.
Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer.
Al-Tweigeri T, Elshenawy M, Badran A, Omar A, Suleman K, Al Malik O, Anwar I, Jastaniya N, Tulbah A, Al Shabanah M, Ajarim D, Al Sayed A. Al-Tweigeri T, et al. Among authors: al shabanah m, al sayed a, al malik o. J Oncol. 2021 Feb 12;2021:6639763. doi: 10.1155/2021/6639763. eCollection 2021. J Oncol. 2021. PMID: 33628241 Free PMC article.
Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
Gaafar A, Aljurf MD, Al-Sulaiman A, Iqniebi A, Manogaran PS, Mohamed GE, Al-Sayed A, Alzahrani H, Alsharif F, Mohareb F, Ajarim D, Tabakhi A, Al-Hussein K. Gaafar A, et al. Among authors: al sayed a, al sulaiman a, al hussein k. Exp Hematol. 2009 Jul;37(7):838-48. doi: 10.1016/j.exphem.2009.04.003. Epub 2009 May 14. Exp Hematol. 2009. PMID: 19446661 Free article.
A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin-docetaxel with or without trastuzumab in locally advanced breast cancer.
A L-Tweigeri T, AlSayed A, Alawadi S, Ibrahim M, Ashour W, Jaafar H, Abulkhair O, A L-Abdulkarim H, Khalid H, Ajarim D; Gulf Oncology Research Group (GORG-001). A L-Tweigeri T, et al. Cancer Chemother Pharmacol. 2016 Jan;77(1):147-53. doi: 10.1007/s00280-015-2906-5. Epub 2015 Nov 12. Cancer Chemother Pharmacol. 2016. PMID: 26563257 Clinical Trial.
73 results